-
Je něco špatně v tomto záznamu ?
ESR/ERS statement paper on lung cancer screening
HU. Kauczor, AM. Baird, TG. Blum, L. Bonomo, C. Bostantzoglou, O. Burghuber, B. Čepická, A. Comanescu, S. Couraud, A. Devaraj, V. Jespersen, S. Morozov, IN. Agmon, N. Peled, P. Powell, H. Prosch, S. Ravara, J. Rawlinson, MP. Revel, M. Silva, A....
Jazyk angličtina Země Německo
Typ dokumentu časopisecké články, přehledy
NLK
ProQuest Central
od 1997-01-01 do Před 1 rokem
CINAHL Plus with Full Text (EBSCOhost)
od 2008-01-01 do Před 1 rokem
Medline Complete (EBSCOhost)
od 2000-01-01 do Před 1 rokem
Nursing & Allied Health Database (ProQuest)
od 1997-01-01 do Před 1 rokem
Health & Medicine (ProQuest)
od 1997-01-01 do Před 1 rokem
- MeSH
- časná detekce nádoru metody MeSH
- konsensus * MeSH
- lidé MeSH
- nádory plic diagnóza MeSH
- registrace MeSH
- rozhodování * MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
- Geografické názvy
- Evropa MeSH
In Europe, lung cancer ranks third among the most common cancers, remaining the biggest killer. Since the publication of the first European Society of Radiology and European Respiratory Society joint white paper on lung cancer screening (LCS) in 2015, many new findings have been published and discussions have increased considerably. Thus, this updated expert opinion represents a narrative, non-systematic review of the evidence from LCS trials and description of the current practice of LCS as well as aspects that have not received adequate attention until now. Reaching out to the potential participants (persons at high risk), optimal communication and shared decision-making will be key starting points. Furthermore, standards for infrastructure, pathways and quality assurance are pivotal, including promoting tobacco cessation, benefits and harms, overdiagnosis, quality, minimum radiation exposure, definition of management of positive screen results and incidental findings linked to respective actions as well as cost-effectiveness. This requires a multidisciplinary team with experts from pulmonology and radiology as well as thoracic oncologists, thoracic surgeons, pathologists, family doctors, patient representatives and others. The ESR and ERS agree that Europe's health systems need to adapt to allow citizens to benefit from organised pathways, rather than unsupervised initiatives, to allow early diagnosis of lung cancer and reduce the mortality rate. Now is the time to set up and conduct demonstration programmes focusing, among other points, on methodology, standardisation, tobacco cessation, education on healthy lifestyle, cost-effectiveness and a central registry.Key Points• Pulmonologists and radiologists both have key roles in the set up of multidisciplinary LCS teams with experts from many other fields.• Pulmonologists identify people eligible for LCS, reach out to family doctors, share the decision-making process and promote tobacco cessation.• Radiologists ensure appropriate image quality, minimum dose and a standardised reading/reporting algorithm, together with a clear definition of a "positive screen".• Strict algorithms define the exact management of screen-detected nodules and incidental findings.• For LCS to be (cost-)effective, it has to target a population defined by risk prediction models.
7th Respiratory Medicine Department Athens Chest Hospital Sotiria Athens Greece
Central Pathology Laboratory Trinity College Dublin St James's Hospital Dublin Ireland
Community Health Association Romania Bucharest Romania
Department of Pneumology Klinikum Emil von Behring Berlin Germany
Department of Radiology Policlinico Universitario Agostino Gemelli Rome Italy
European Lung Foundation Sheffield UK
Intensive Care Unit Korgialeneion Benakeion General Hospital Athens Greece
Internal Medicine F Rabin Medical Center Petah Tikva Israel
Otto Wagner Hospital Vienna Vienna Austria
Pulmonology Universitair Ziekenhuis Antwerpen Edegem Belgium
Radiology Department Cochin Hospital APHP Paris France
Radiology University Hospital of Antwerp Edegem Belgium
Royal Brompton Hospital London UK
S E N A s r o Prague Czech Republic
Section of Radiology Department of Medicine and Surgery University of Parma Parma Italy
Thoracic Cancer Unit Rabin Medical Center Petach Tiqwa Israel
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20028125
- 003
- CZ-PrNML
- 005
- 20210114153033.0
- 007
- ta
- 008
- 210105s2020 gw f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s00330-020-06727-7 $2 doi
- 035 __
- $a (PubMed)32052170
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Kauczor, Hans-Ulrich $u Department of Diagnostic and Interventional Radiology, University Hospital Heidelberg, German Center of Lung Research, INF 110, 69120, Heidelberg, Germany. hans-ulrich.kauczor@med.uni-heidelberg.de.
- 245 10
- $a ESR/ERS statement paper on lung cancer screening / $c HU. Kauczor, AM. Baird, TG. Blum, L. Bonomo, C. Bostantzoglou, O. Burghuber, B. Čepická, A. Comanescu, S. Couraud, A. Devaraj, V. Jespersen, S. Morozov, IN. Agmon, N. Peled, P. Powell, H. Prosch, S. Ravara, J. Rawlinson, MP. Revel, M. Silva, A. Snoeckx, B. van Ginneken, JP. van Meerbeeck, C. Vardavas, O. von Stackelberg, M. Gaga, European Society of Radiology (ESR) and the European Respiratory Society (ERS),
- 520 9_
- $a In Europe, lung cancer ranks third among the most common cancers, remaining the biggest killer. Since the publication of the first European Society of Radiology and European Respiratory Society joint white paper on lung cancer screening (LCS) in 2015, many new findings have been published and discussions have increased considerably. Thus, this updated expert opinion represents a narrative, non-systematic review of the evidence from LCS trials and description of the current practice of LCS as well as aspects that have not received adequate attention until now. Reaching out to the potential participants (persons at high risk), optimal communication and shared decision-making will be key starting points. Furthermore, standards for infrastructure, pathways and quality assurance are pivotal, including promoting tobacco cessation, benefits and harms, overdiagnosis, quality, minimum radiation exposure, definition of management of positive screen results and incidental findings linked to respective actions as well as cost-effectiveness. This requires a multidisciplinary team with experts from pulmonology and radiology as well as thoracic oncologists, thoracic surgeons, pathologists, family doctors, patient representatives and others. The ESR and ERS agree that Europe's health systems need to adapt to allow citizens to benefit from organised pathways, rather than unsupervised initiatives, to allow early diagnosis of lung cancer and reduce the mortality rate. Now is the time to set up and conduct demonstration programmes focusing, among other points, on methodology, standardisation, tobacco cessation, education on healthy lifestyle, cost-effectiveness and a central registry.Key Points• Pulmonologists and radiologists both have key roles in the set up of multidisciplinary LCS teams with experts from many other fields.• Pulmonologists identify people eligible for LCS, reach out to family doctors, share the decision-making process and promote tobacco cessation.• Radiologists ensure appropriate image quality, minimum dose and a standardised reading/reporting algorithm, together with a clear definition of a "positive screen".• Strict algorithms define the exact management of screen-detected nodules and incidental findings.• For LCS to be (cost-)effective, it has to target a population defined by risk prediction models.
- 650 12
- $a konsensus $7 D032921
- 650 12
- $a rozhodování $7 D003657
- 650 _2
- $a časná detekce nádoru $x metody $7 D055088
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a nádory plic $x diagnóza $7 D008175
- 650 _2
- $a registrace $7 D012042
- 651 _2
- $a Evropa $7 D005060
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Baird, Anne-Marie $u Central Pathology Laboratory, Trinity College Dublin, St. James's Hospital, Dublin, Ireland.
- 700 1_
- $a Blum, Torsten Gerriet $u Department of Pneumology, Klinikum Emil von Behring, Berlin, Germany.
- 700 1_
- $a Bonomo, Lorenzo $u Department of Radiology, Policlinico Universitario Agostino Gemelli, Rome, Italy.
- 700 1_
- $a Bostantzoglou, Clementine $u Intensive Care Unit, Korgialeneion-Benakeion General Hospital, Athens, Greece.
- 700 1_
- $a Burghuber, Otto $u Otto Wagner Hospital Vienna, Vienna, Austria.
- 700 1_
- $a Čepická, Blanka $u S.E.N.A. s.r.o, Prague, Czech Republic.
- 700 1_
- $a Comanescu, Alina $u Community Health Association Romania, Bucharest, Romania.
- 700 1_
- $a Couraud, Sébastien $u Service de Pneumologie et Oncologie Thoracique, Hospices Civils de Lyon, Sud, Pierre Bénite, Lyon, CH, France. Faculté de Médecine et de Maïeutique Lyon Sud - Charles Mérieux, Université Claude Bernard Lyon I, Oullins, France.
- 700 1_
- $a Devaraj, Anand $u Royal Brompton Hospital, London, UK.
- 700 1_
- $a Jespersen, Vagn $u , Holstebro, Denmark.
- 700 1_
- $a Morozov, Sergey $u Department of Health Care of Moscow, Research and Practical Clinical Center of Diagnostics and Telemedicine Technologies, Moscow, Russian Federation.
- 700 1_
- $a Agmon, Inbar Nardi $u Internal Medicine F, Rabin Medical Center, Petah Tikva, Israel.
- 700 1_
- $a Peled, Nir $u Thoracic Cancer Unit, Rabin Medical Center, Petach Tiqwa, Israel.
- 700 1_
- $a Powell, Pippa $u European Lung Foundation, Sheffield, UK.
- 700 1_
- $a Prosch, Helmut $u Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Vienna, Austria.
- 700 1_
- $a Ravara, Sofia $u Medical Sciences, Faculty of Health Sciences, University of Beira Interior, Covilha, Portugal. Tobacco Cessation Unit, CHCB University Hospital, Covilha, Portugal.
- 700 1_
- $a Rawlinson, Janette $u ELF Advocacy, Tipton, UK.
- 700 1_
- $a Revel, Marie-Pierre $u Radiology Department, Cochin Hospital, APHP, Paris, France.
- 700 1_
- $a Silva, Mario $u Section of Radiology, Department of Medicine and Surgery (DiMeC), University of Parma, Parma, Italy.
- 700 1_
- $a Snoeckx, Annemiek $u Radiology, University Hospital of Antwerp, Edegem, Belgium.
- 700 1_
- $a van Ginneken, Bram $u Image Sciences Institute, University Medical Centre, Utrecht, The Netherlands. Department of Radiology, Nijmegen Medical Centre, Nijmegen, The Netherlands.
- 700 1_
- $a van Meerbeeck, Jan P $u Pulmonology, Universitair Ziekenhuis Antwerpen, Edegem, Belgium.
- 700 1_
- $a Vardavas, Constantine $u Clinic of Social and Family Medicine, Faculty of Medicine, University of Crete, Heraklion, Greece. Center for Global Tobacco Control, Department of Society, Human Development and Health, Harvard School of Public Health, Boston, MA, USA.
- 700 1_
- $a von Stackelberg, Oyunbileg $u Department of Diagnostic and Interventional Radiology, University Hospital Heidelberg, German Center of Lung Research, INF 110, 69120, Heidelberg, Germany.
- 700 1_
- $a Gaga, Mina $u 7th Respiratory Medicine Department, Athens Chest Hospital Sotiria, Athens, Greece.
- 710 2_
- $a European Society of Radiology (ESR) and the European Respiratory Society (ERS)
- 773 0_
- $w MED00009646 $t European radiology $x 1432-1084 $g Roč. 30, č. 6 (2020), s. 3277-3294
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32052170 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20210105 $b ABA008
- 991 __
- $a 20210114153030 $b ABA008
- 999 __
- $a ok $b bmc $g 1608460 $s 1119305
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 30 $c 6 $d 3277-3294 $e 20200212 $i 1432-1084 $m European radiology $n Eur Radiol $x MED00009646
- LZP __
- $a Pubmed-20210105
